Visual Perception Difficulties After Stroke
Launched by DURHAM UNIVERSITY · Jul 31, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Visual Perception Difficulties After Stroke," is studying how well a new screening tool called the Oxford Visual Perception Screening (OxVPS) can detect visual perception problems in people who have survived a stroke. Visual perception refers to how the brain interprets what the eyes see, and difficulties in this area can make daily activities challenging for stroke survivors. The trial aims to see how accurately the OxVPS identifies these issues compared to the standard testing method currently used.
To participate in this study, individuals must have been diagnosed with a stroke within the last six weeks, which could be either an ischemic stroke (caused by a blockage in blood flow) or an intracerebral hemorrhage (bleeding in the brain). Eligible participants will complete both the OxVPS and the standard screening tool during the trial. The study is currently looking for participants aged 65 to 74, and it is open to everyone regardless of gender. However, those who cannot understand English, have trouble following simple instructions, or are unable to concentrate for about 15 minutes will not be able to participate. This research is important because it could help improve the way we identify and support stroke survivors facing visual perception challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with a clinical diagnosis of stroke (ischemic stroke and/or intracerebral haemorrhage).
- • Within 6 weeks of confirmed stroke.
- Exclusion Criteria:
- • Insufficient understanding of English
- • Clinical concerns that patient is unable follow simple instructions.
- • Clinical concerns that patient is unable to concentrate for 15 minutes.
- • No capacity to provide informed consent.
About Durham University
Durham University, a prestigious institution located in the United Kingdom, is renowned for its commitment to advancing research and innovation across various disciplines, including health sciences. As a clinical trial sponsor, Durham University leverages its rich academic resources and interdisciplinary expertise to design, conduct, and oversee clinical studies aimed at improving patient outcomes and informing healthcare practices. The university's dedication to ethical research and collaboration ensures rigorous adherence to regulatory standards, fostering an environment that promotes scientific integrity and impactful findings. Through its clinical trials, Durham University aims to contribute valuable insights that enhance the understanding and treatment of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Gateshead, , United Kingdom
Abingdon, , United Kingdom
Bishop Auckland, , United Kingdom
Patients applied
Trial Officials
Kathleen Vancleef, PhD
Principal Investigator
Durham University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported